Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEVOLAM: Pevonedistat Plus Azacitidine vs Azacitidine in Older/Unfit Newly Diagnosed AML
NCT04090736Phase 3Active, not recruiting
- Sponsor
- Fundación PETHEMA
- Start
- Sep 2019
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pevonedistat in acute myeloid leukemia (AML), sponsored by Fundación PETHEMA. Started Sep 2019; status: active, not recruiting.
02
Drugs
pevonedistat
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT04090736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04090736.